Zbrzeżniak Jakub Maciej, Paradowska-Stankiewicz Iwona
Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy.
Przegl Epidemiol. 2024 Dec 10;78(3):345-350. doi: 10.32394/pe/195135. Epub 2024 Nov 6.
In Poland, Lyme disease has been subject to mandatory reporting and registration since 1996, and following EU law, cases of neuroborreliosis have been reported to the European Centre for Disease Prevention and Control (ECDC) since 2019. Lyme disease is transmitted by ticks of the Ixodes genus, and humans become infected through the bite of an infected tick. Due to the varied symptoms, diagnosis can be difficult and usually involves two-stage serological diagnostics. The aim of the study was to assess the epidemiological situation of Lyme disease in Poland in 2022 compared to the situation in previous years.
The epidemiological situation of Lyme disease in Poland was assessed on the basis of the data sent to NIPH NIH - NRI by voivodeship sanitary-epidemiological stations and published in the bulletin "Infectious diseases and poisoning in Poland in 2022".
In 2022, 17 369 cases of Lyme disease were registered, including 776 hospitalizations. This was a significant increase in cases by 38.96% and hospitalizations by 88.81% compared to the previous year. The seasonality that characterizes Lyme disease was noticeable in individual quarters, i.e. an increase in the number of cases from 1 151 in Q1 to 7 267 in Q3 and a decrease in Q4 to 5 708. At the voivodeship level, the highest incidence was recorded in the Podlaskie (81.2 per 100 000), Małopolskie (79.8 per 100 000) and Lubelskie (76.8 per 100 000) voivodeships.
The epidemiological situation of Lyme disease is gradually returning to the state before the COVID-19 pandemic. The percentage of hospitalized cases increased slightly (from 3.3% in 2021 to 4.5% in 2022), which, combined with the increase in the number of cases, meant an increase in the number of hospitalizations due to Lyme disease by almost 89%. The highest incidence was consistently observed in the eastern part of Poland (Podlaskie, Warmińsko-mazurskie, Lubelskie voivodeships).
在波兰,自1996年起莱姆病就需进行强制报告和登记,并且自2019年起,按照欧盟法律,神经莱姆病病例需向欧洲疾病预防控制中心(ECDC)报告。莱姆病由硬蜱属的蜱传播,人类通过被感染的蜱叮咬而感染。由于症状多样,诊断可能会很困难,通常需要进行两阶段血清学诊断。本研究的目的是评估2022年波兰莱姆病的流行病学情况,并与前几年的情况进行比较。
基于各省份卫生防疫站发送至国家公共卫生研究所 - 国家卫生研究院(NIPH NIH - NRI)的数据,并发表在《2022年波兰的传染病与中毒》公告中,对波兰莱姆病的流行病学情况进行了评估。
2022年,共登记了17369例莱姆病病例,其中776例住院治疗。与上一年相比,病例数显著增加了38.96%,住院人数增加了88.81%。莱姆病的季节性在各个季度都很明显,即病例数从第一季度的1151例增加到第三季度的7267例,第四季度降至5708例。在省份层面,发病率最高的是波德拉谢省(每10万人中有81.2例)、小波兰省(每10万人中有79.8例)和卢布林省(每10万人中有76.8例)。
莱姆病的流行病学情况正逐渐恢复到新冠疫情之前的状态。住院病例的百分比略有增加(从2021年的3.3%增至2022年的4.5%),这与病例数的增加相结合,意味着因莱姆病住院的人数增加了近89%。波兰东部地区(波德拉谢省、瓦尔米亚 - 马祖里省、卢布林省)的发病率一直最高。